Diverse presentations of transthyretin cardiac amyloidosis beyond heart failure with preserved ejection fraction

被引:0
|
作者
Achten, A. Anouk [1 ]
Muller, S. [2 ]
Sanders-Van Wijk, S. [3 ]
Van Empel, V. P. M. [1 ]
Van der Meer, M. G. [2 ]
Zwetsloot, P. [2 ]
Te Riele, A. S. J. M. [2 ]
Oerlemans, M. I. F. J. [2 ]
Knackstedt, C. [1 ]
机构
[1] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands
[2] Cardiol Ctr Utrecht, Cardiol, Utrecht, Netherlands
[3] Zuyderland Med Ctr, Cardiol, Heerlen, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:77 / 78
页数:2
相关论文
共 50 条
  • [1] Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction
    Healy, L.
    Giblin, G.
    Gray, A.
    Starr, N.
    Murphy, L.
    O'Sullivan, D.
    Kavanagh, E.
    Howley, C.
    Tracey, C.
    Morrin, E.
    Mcdaid, A.
    Clarke, A.
    O'Neill, J. O.
    Joyce, E.
    O'Connell, M.
    Mahon, N. G.
    ESC HEART FAILURE, 2025, 12 (02): : 1176 - 1182
  • [2] Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction
    Griffin, Jan M.
    Maurer, Mathew S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2021, 31 (01) : 59 - 66
  • [3] Transthyretin Cardiac Amyloidosis in Patients With Acute Heart Failure and Preserved Ejection Fraction
    Horvath, Sofia A.
    Lo Presti, Saberio
    McCloskey, Veronica
    Mihos, Christos G.
    Santana, Orlando
    CIRCULATION, 2018, 138
  • [4] Diagnosing heart failure with preserved ejection fraction in cardiac amyloidosis or diagnosing cardiac amyloidosis in heart failure with preserved ejection fraction?
    Lund, Lars H.
    Eldhagen, Per
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (12) : 2387 - 2389
  • [5] A SIMPLE SCORE TO PREDICT TRANSTHYRETIN CARDIAC AMYLOIDOSIS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Davies, Daniel
    Minamisawa, Masatoshi
    Scott, Christopher
    Grogan, Martha
    Dispenzieri, Angela
    Chareonthaitawee, Panithaya
    Shah, Amil
    Shah, Sanjiv
    Solomon, Scott
    Redfield, Margaret
    AbouEzzeddine, Omar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 521 - 521
  • [6] The prevalence of transthyretin amyloidosis in patients with heart failure with preserved ejection fraction
    Oh, J. Jaewon
    Kim, S. E.
    Lee, S.
    Lee, C. J.
    Kang, S. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 359 - 359
  • [7] Prevalence of transthyretin amyloidosis in patients with heart failure with preserved ejection fraction
    Naito, T.
    Nakamura, K.
    Abe, Y.
    Sakuragi, S.
    Kihara, H.
    Okizaki, A.
    Kawai, Y.
    Watanabe, H.
    Yoshikawa, M.
    Takaishi, A.
    Fujio, H.
    Otsuka, H.
    Ogura, S.
    Nomura, N.
    Ito, H.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1079 - 1079
  • [8] True prevalence of transthyretin cardiac amyloidosis in an unselected heart failure with preserved ejection fraction cohort
    Achten, A. Anouk
    Van Empel, V. P. M.
    Weerts, J.
    Mourmans, S.
    Rocca, H. P. Brunner-La
    Wijk, S. Sanders-Van
    Knackstedt, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 47 - 48
  • [9] PREVALENCE OF TRANSTHYRETIN CARDIAC AMYLOIDOSIS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: A POPULATION BASED STUDY
    Abou-Ezzeddine, Omar Farid
    Davies, Daniel
    Sexton, Jasmine A.
    Scott, Christopher G.
    Fayyaz, Ahmed
    Akhiyat, Nadia
    Stromme, Trevor A.
    Askew, John W.
    McKie, Paul
    Noseworthy, Peter
    Dunlay, Shannon
    Borlaug, Barry
    Chareonthaitawee, Panithaya
    Johnson, Geoffrey
    Dispenzieri, Angela
    Grogan, Martha
    Redfield, Margaret M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 691 - 691
  • [10] Transthyretin Cardiac Amyloidosis: Pathogenesis, Treatments, and Emerging Role in Heart Failure with Preserved Ejection Fraction
    Ton, Van-Khue
    Mukherjee, Monica
    Judge, Daniel P.
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2014, 8 : 39 - 44